Research team finds possible clue to progression of multiple sclerosis
Wayne State University School of Medicine researchers, working with colleagues in Canada, have found that one or more substances produced by a type of immune cell in people with multiple sclerosis (MS) may play a role in ...
Neuroscience
Jul 31, 2012 |
not rated yet |
0
|
Tumor cells' inner workings predict cancer progression
Using a new assay method to study tumor cells, researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center have found evidence of clonal evolution in chronic ...
Cancer
Jul 27, 2012 |
5 / 5 (1) |
0
|
Lymph node roundabout: Researchers probe origin of optimized antibodies against infections
An organism's ability to make new antibodies and use them to optimize its own immune defenses is of central importance in the fight against pathogens. In the case of severe infections, the overall relative ...
Immunology
Jun 28, 2012 |
not rated yet |
0
Gene signature helps identify risk of relapse in lung cancer patients
A new genetic signature identified by Spanish researchers may provide doctors with robust and objective information about which patients with early stage lung cancer are at low or high risk of relapse following surgery, investigators ...
Cancer
Apr 18, 2012 |
5 / 5 (1) |
0
The existence of neutrophils in the spleen discovered
For the first time, it has been discovered that neutrophils exist in the spleen without there being an infection. This important finding made by the research group on the Biology of B Cells of IMIM (Hospital ...
Medical research
Dec 25, 2011 |
4.6 / 5 (5) |
1
|
New study shows how B cells may generate antibodies after vaccination
Steve Reiner, MD, professor of Medicine, and Burton Barnett, a doctoral student in the Reiner lab at the Perelman School of Medicine at the University of Pennsylvania, have shown how immune cells, called B ...
Medical research
Dec 15, 2011 |
5 / 5 (2) |
0
|
B cell receptor inhibitor causes chronic lymphocytic leukemia remission
A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, investigators report at the 53rd Annual Meeting ...
Cancer
Dec 11, 2011 |
5 / 5 (2) |
0
Stem cells central to pathogenesis of mature lymphoid tumors
New research suggests that blood stem cells can be involved in the generation of leukemia, even when the leukemia is caused by the abnormal proliferation of mature cells. The study, published by Cell Press in the August 16th ...
Cancer
Aug 15, 2011 |
not rated yet |
0
- Pages: 1 2
